These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10192736)

  • 1. The effects of a new ultra-short-acting beta-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass.
    Ahmet I; Fukushima N; Sawa Y; Masai T; Kadoba K; Kagisaki K; Chang JC; Yamaguchi T; Matsuda H
    Surg Today; 1999; 29(3):248-54. PubMed ID: 10192736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.
    Sugiyama A; Takahara A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):70-7. PubMed ID: 10413070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations.
    Motomura S; Hagihara A; Narumi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):431-40. PubMed ID: 9514189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a highly cardioselective ultra short-acting beta-blocker, ONO-1101.
    Iguchi S; Iwamura H; Nishizaki M; Hayashi A; Senokuchi K; Kobayashi K; Sakaki K; Hachiya K; Ichioka Y; Kawamura M
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1462-9. PubMed ID: 1356643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
    Muraki K; Nakagawa H; Nagano N; Henmi S; Kawasumi H; Nakanishi T; Imaizumi K; Tokuno T; Atsuki K; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1996 Aug; 278(2):555-63. PubMed ID: 8768704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esmolol before 80 min of cardiac arrest with oxygenated cold blood cardioplegia alleviates systolic dysfunction. An experimental study in pigs.
    Fannelop T; Dahle GO; Matre K; Moen CA; Mongstad A; Eliassen F; Segadal L; Grong K
    Eur J Cardiothorac Surg; 2008 Jan; 33(1):9-17. PubMed ID: 18032058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting].
    Iwasawa K; Nakagawa H; Katou M; Yonezawa K; Nishizawa M; Yanagiya N
    Masui; 2005 Apr; 54(4):402-7. PubMed ID: 15852628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].
    Mio Y
    Masui; 2006 Jul; 55(7):841-8. PubMed ID: 16856544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esmolol improves left ventricular function via enhanced beta-adrenergic receptor signaling in a canine model of coronary revascularization.
    Booth JV; Spahn DR; McRae RL; Chesnut LC; El-Moalem H; Atwell DM; Leone BJ; Schwinn DA
    Anesthesiology; 2002 Jul; 97(1):162-9. PubMed ID: 12131118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of landiolol and combined use of landiolol and olprinone on hemodynamics in patients undergoing off-pump coronary artery bypass grafting].
    Tachikawa M; Shimazaki M; Arai T; Saima S; Adachi E; Okuda Y
    Masui; 2012 Jun; 61(6):566-73. PubMed ID: 22746016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an ultrashort-acting beta-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation.
    Kitamura A; Sakamoto A; Inoue T; Ogawa R
    Eur J Clin Pharmacol; 1997; 51(6):467-71. PubMed ID: 9112061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker.
    Takahata T; Yasui-Furukori N; Sakamoto J; Suto K; Suto T; Tateishi T; Munakata A
    Drugs R D; 2005; 6(6):385-94. PubMed ID: 16274261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of esmolol given during cardiopulmonary bypass.
    Cork RC; Kramer TH; Dreischmeier B; Behr S; DiNardo JA
    Anesth Analg; 1995 Jan; 80(1):28-40. PubMed ID: 7802296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography.
    Cork RC; Azari DM; McQueen KA; Aufderheide S; Mitchell M; Naraghi M
    Anesth Analg; 1995 Aug; 81(2):219-24. PubMed ID: 7618705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
    Kobayashi S; Susa T; Tanaka T; Murakami W; Fukuta S; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Okamura T; Yano M; Matsuzaki M
    Circ J; 2012; 76(7):1646-53. PubMed ID: 22481100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.
    Shibata S; Okamoto Y; Endo S; Ono K
    J Pharmacol Sci; 2012; 118(2):255-65. PubMed ID: 22293301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A short-acting beta-blocker, landiolol, attenuates systolic anterior motion of the mitral valve after mitral valve annuloplasty.
    Omae T; Tsuneyoshi I; Higashi A; Matsunaga A; Sakata R; Kanmura Y
    J Anesth; 2008; 22(3):286-9. PubMed ID: 18685936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.